Zhu Y, Zhang Y, Hu X, Wang M, et al. PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy. J Cancer Res Clin Oncol 2022;148:3557-3566.
PMID: 35857126